Boston Scientific’s third-quarter revenue topped $5 billion, up 20.3% year over year. Growth eased slightly from the second quarter, when…

Thermo Fisher Scientific’s plan for growth is paying off as the biopharma service provider and supplier posted a sales bump…

Walmart will become the first U.S. retailer to sell Abbott’s continuous glucose monitoring device as the medtech giant looks to…

It is financial reporting season, and a few major medtech companies posted third-quarter sales growth. Quest Diagnostics and Danaher both…

A retinal implant developed by Science Corp. has for the first time restored some functional vision to patients with a…

Boston Scientific shelled out $533 million to buy up the remaining equity it had in Nalu Medical, a private company…

Cancer treatment developer HistoSonics reeled in $250 million in an oversubscribed series D round of financing two months after a…

Two European-based biotechs—Indivi of Switzerland and Clouds of Care of Belgium—have inked a collaboration deal with the goal of leveraging…

Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a…

Sophia Genetics has launched an artificial-intelligence-powered tool that creates virtual copies of patients, known as digital twins, that could one…